Sfoglia per AUTORE
SCIASCIA S
Collezione ASL Città di Torino

  

Items : 84

Diagnostic, research, and real-life effect of the 2023 EULAR-ACR classification criteria for antiphospholipid syndrome. in The Lancet. Rheumatology / Lancet Rheumatol. 2025 Mar 7:S2665-9913(24)00396-5. doi: 10.1016/S2665-9913(24)00396-5.
2025
ASL Città di Torino

Schreiber K; Aguilera S; Amengual O; Cohen H; Castro Oliveira De Andrade D; Duarte-García A; Gerosa M; Nelson-Piercy C; Radin M; Raio L; Sciascia S;

Biological therapies in thrombocytopenia and primary antiphospholipid syndrome: where are we now? in Expert opinion on biological therapy / Expert Opin Biol Ther. 2025 Mar 28. doi: 10.1080/14712598.2025.2484844.
2025
ASL Città di Torino

Radin M; Barinotti A; Galarza D; Cecchi I; Camerlo S; Vaccarino A; Roccatello D; Morotti A; Sciascia S;

Is it time for treat-to-target in antiphospholipid syndrome? in Autoimmunity reviews / Autoimmun Rev. 2025 Jan 3;24(1):103690. doi: 10.1016/j.autrev.2024.103690. Epub 2024 Nov 19.
2025
ASL Città di Torino

Sciascia S; Barilaro G; Radin M; Cervera R; Roccatello D;

How We Treat ANCA-Associated Vasculitis: A Focus on the Maintenance Therapy. in Journal of clinical medicine / J Clin Med. 2025 Jan 2;14(1):208. doi: 10.3390/jcm14010208.
2025
ASL Città di Torino

Roccatello D; Fenoglio R; De Simone E; Sciascia S;

Cryfibrinogen-Associated Glomerulonephritis and Monoclonal Gammopathy of Renal Significance-Case Report and Literature Review. in Journal of clinical medicine / J Clin Med. 2025 Feb 28;14(5):1656. doi: 10.3390/jcm14051656.
2025
ASL Città di Torino
AOU Città della Salute di Torino

Roccatello D; Sciascia S; Fenoglio R; Milan M; Barreca A; Ferro M; Solfietti L; Terzolo E;

2025
ASL Città di Torino

Ahmadzadeh Y; Magder LS; de Andrade DCO; Paredes-Ruiz D; Tektonidou MG; Pengo V; Sciascia S; Andreoli L; Signorelli F; Fortin PR; Efthymiou M; Belmont HM; Barilaro G; Clarke AE; Atsumi T; López-Pedrera C; Knight JS; Branch DW; Willis R; Kello N; Zhang Z; Almaraz ER; Artim-Esen B; Pardos-Gea J; Pons-Estel G; Pazzola G; Shi H; Duarte-García A; Thaler J; et alii...

The Italian Society for Rheumatology guidelines on reproductive health in patients with rheumatic diseases. in Reumatismo / Reumatismo. 2025 Feb 13;77(1). doi: 10.4081/reumatismo.2025.1752. Epub 2025 Feb 12.
2025
ASL Novara
ASL Città di Torino

Truglia S; Tonolo S; Rozza D; Sciascia S; Orlandi M; Padovan M; Motta M; Mosca M; Morano D; Ianniello A; Larosa M; Hoxa A; Gerosa M; Gerardi MC; Fredi M; El Auofy K; Di Poi E; Cuomo G; Chimenti MS; Conigliaro P; Crisafulli F; Brucato AL; Carrara G; Beretta E; Crotti C; Ughi N; Urban ML; Zanetti A; Zatti S; et alii...

From Multimorbidity to Network Medicine in Patients with Rheumatic Diseases. in Rheumatology and therapy / Rheumatol Ther. 2025 Feb;12(1):1-24. doi: 10.1007/s40744-024-00724-8. Epub 2024 Nov 27.
2025
ASL Città di Torino

Gilcrease W; Manfredi L; Sciascia S; Ricceri F;

Extremely Long-Lasting B-cell Depletion and BAFFling Effects Following Obinutuzumab-Based Regimen in Lupus Nephritis. in Kidney international reports / Kidney Int Rep. 2024 Aug 10;9(10):3079-3080. doi: 10.1016/j.ekir.2024.08.008. eCollection 2024 Oct.
2024
ASL Città di Torino

Roccatello D; Sciascia S; De Simone E; Schindler T; Martins E; Mao HA; Rossi D; Fenoglio R;

2024
ASL Città di Torino

Sciascia S; Ferrara G; Roccatello L; Rubini E; Foddai SG; Radin M; Cecchi I; Rossi D; Barinotti A; Ricceri F; Gilcrease W; Baldovino S; Ferreira Poshar A; Conti A; Fenoglio R;

Lymphatic System and the Kidney: From Lymphangiogenesis to Renal Inflammation and Fibrosis Development. in International journal of molecular sciences / Int J Mol Sci. 2024 Mar 1;25(5):2853. doi: 10.3390/ijms25052853.
2024
ASL Città di Torino

Stasi E; Sciascia S; Naretto C; Baldovino S; Roccatello D;

Pediatric Presentation of Antiphospholipid Syndrome: A Review of Recent Literature With Estimation of Local Prevalence. in Seminars in thrombosis and hemostasis / Semin Thromb Hemost. 2024 Mar;50(2):182-187. doi: 10.1055/s-0043-1764472. Epub 2023 Mar 20.
2024
ASL Città di Torino

Radin M; Cecchi I; Arbrile M; Montin D; Farinasso L; Cioffi M; Foddai SG; Barinotti A; Menegatti E; Baldovino S; Sciascia S; Roccatello D;

Might maintenance therapy be discontinued once clinical remission is achieved in ANCA-associated vasculitis? in Autoimmunity reviews / Autoimmun Rev. 2024 Jan;23(1):103438. doi: 10.1016/j.autrev.2023.103438. Epub 2023 Aug 30.
2024
ASL Città di Torino

Roccatello D; Padoan R; Sciascia S; Iorio L; Nic An Ríogh E; Little MA;

Can anticoagulation be withdrawn in APS patients after aPL negativization? in Autoimmunity reviews / Autoimmun Rev. 2024 Jan;23(1):103427. doi: 10.1016/j.autrev.2023.103427. Epub 2023 Aug 25.
2024
ASL Città di Torino

Cuadrado MJ; Tincani A; Enriquez Merayo E; Moschetti L; Sciascia S;

Epidemiology of antiphospholipid syndrome: macro- and microvascular manifestations. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2024 Feb 6;63(SI):SI24-SI36. doi: 10.1093/rheumatology/kead571.
2024
ASL Città di Torino

Gaspar P; Sciascia S; Tektonidou MG;

Lupus anticoagulant mixing studies and normalization of results how best to proceed. in International journal of laboratory hematology / Int J Lab Hematol. 2024 Feb;46(1):183-189. doi: 10.1111/ijlh.14187. Epub 2023 Oct 17.
2024
ASL Città di Torino
AO Ordine Mauriziano
AOU Città della Salute di Torino

Valesella P; Sciascia S; Sampietro S; Rolla R; Papandrea M; Muccini E; Bairo A; Cabodi D; Beltrami E; Montaruli B;

Syndemic approach to chronic kidney disease, cardiovascular disease and educational level: a longitudinal cohort study in northwest Italy. in Journal of epidemiology and community health / J Epidemiol Community Health. 2024 Dec 4:jech-2024-222370. doi: 10.1136/jech-2024-222370.
2024
ASL Città di Torino
ASL Torino 3

Destefanis C; Gilcrease W; Sciascia S; Macciotta A; Gnavi R; Milani L; Dansero L; Ricceri F;

Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-D Report: Multicriteria Decision Analysis. in Arthritis care & research / Arthritis Care Res (Hoboken). 2024 Dec;76(12):1617-1625. doi: 10.1002/acr.25415. Epub 2024 Sep 30.
2024
ASL Città di Torino

Barbhaiya M; Zuily S; Amigo MC; Andrade D; Avcin T; Bertolaccini ML; Branch DW; Costedoat-Chalumeau N; Crowther M; Ramires de Jesus G; Devreese KMJ; Frances C; Garcia D; Gómez-Puerta JA; Guillemin F; Levine SR; Levy RA; Lockshin MD; Ortel TL; Petri M; Sanna G; Sciascia S; Seshan SV; Tektonidou MG; Wahl D; Willis R; Yelnik C; Hendry A; Naden R; et alii...

2024
ASL Città di Torino

Blaess J; Geneton S; Goepfert T; Appenzeller S; Bordier G; Davergne T; Fuentes Y; Haglo H; Hambly K; Kinnett-Hopkins D; Su KY; Legge A; Li L; Mak A; Padjen I; Sciascia S; Sheikh SZ; Soriano-Maldonado A; Ugarte-Gil MF; Md Yusof MY; Parodis I; Arnaud L;

From inflammation to renal fibrosis: A one-way road in autoimmunity? in Autoimmunity reviews / Autoimmun Rev. 2024 Apr;23(4):103466. doi: 10.1016/j.autrev.2023.103466. Epub 2023 Oct 15.
2024
ASL Città di Torino

Roccatello D; Lan HY; Sciascia S; Sethi S; Fornoni A; Glassock R;

Case report: Timing of eculizumab treatment in catastrophic antiphospholipid syndrome. in Frontiers in immunology / Front Immunol. 2024 Sep 10;15:1460317. doi: 10.3389/fimmu.2024.1460317. eCollection 2024.
2024
ASL Città di Torino

Carrara C; Mataj B; Gastoldi S; Ruggenenti P; Sciascia S; Roccatello D;

2024
ASL Città di Torino

Iadarola GM; Giorda E; Borca M; Morero D; Sciascia S; Roccatello D;

Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab. in Clinical kidney journal / Clin Kidney J. 2023 May 15;16(9):1465-1468. doi: 10.1093/ckj/sfad111. eCollection 2023 Sep.
2023
ASL Città di Torino

Sciascia S; Rilat MLA; Fenoglio R; Foddai SG; Radin M; Cecchi I; Cinnirella G; Crosasso P; Guidetti MG; Barinotti A; Baldovino S; Menegatti E; Roccatello D;

[Management of Cast Nephropathy]. in Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia / G Ital Nefrol. 2023 Oct 3;40(Suppl 81):2023-S81.
2023
ASL Città di Torino

De Simone E; Fenoglio R; Cortazzi S; Careddu A; Geraci G; Bugliosi F; Sciascia S; Roccatello D;

[Renal Replacement Therapy in Cancer Patients with AKI]. in Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia / G Ital Nefrol. 2023 Oct 3;40(Suppl 81):2023-S81.
2023
ASL Città di Torino

Pozzato M; Fenoglio R; Caruso N; Ceruti C; Amore G; Sciascia S; Roccatello D;

[Renal Side Effects of Novel Molecular Targeted Oncologic Agents]. in Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia / G Ital Nefrol. 2023 Oct 3;40(Suppl 81):2023-S81.
2023
ASL Città di Torino

Fenoglio R; Cortazzi S; Marchisio M; Rabajoli G; Terzolo E; Sciascia S; Roccatello D;

[Cancer and the Kidney: A Deadly Embrace]. in Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia / G Ital Nefrol. 2023 Oct 3;40(Suppl 81):2023-S81.
2023
ASL Città di Torino

Roccatello D; Cortazzi S; Bertinetto F; La Rosa A; Nescis L; Sciascia S; Fenoglio R;

[Management of the Oncological Patient with Chronic Renal Failure]. in Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia / G Ital Nefrol. 2023 Oct 3;40(Suppl 81):2023-S81.
2023
ASL Città di Torino

Fenoglio R; Cortazzi S; Guarino A; Longo R; Caniggia I; Sciascia S; Roccatello D;

The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria. in Arthritis & rheumatology (Hoboken, N.J.) / Arthritis Rheumatol. 2023 Oct;75(10):1687-1702. doi: 10.1002/art.42624. Epub 2023 Aug 28.
2023
ASL Città di Torino

Barbhaiya M; Zuily S; Naden R; Hendry A; Manneville F; Amigo MC; Amoura Z; Andrade D; Andreoli L; Artim-Esen B; Atsumi T; Avcin T; Belmont HM; Bertolaccini ML; Branch DW; Carvalheiras G; Casini A; Cervera R; Cohen H; Costedoat-Chalumeau N; Crowther M; de Jesus G; Delluc A; Desai S; De Sancho M; Devreese KM; Diz-Kucukkaya R; Duarte-Garcia A; Frances C; et alii...

2023 ACR/EULAR antiphospholipid syndrome classification criteria. in Annals of the rheumatic diseases / Ann Rheum Dis. 2023 Oct;82(10):1258-1270. doi: 10.1136/ard-2023-224609. Epub 2023 Aug 28.
2023
ASL Città di Torino

Barbhaiya M; Zuily S; Naden R; Hendry A; Manneville F; Amigo MC; Amoura Z; Andrade D; Andreoli L; Artim-Esen B; Atsumi T; Avcin T; Belmont HM; Bertolaccini ML; Branch DW; Carvalheiras G; Casini A; Cervera R; Cohen H; Costedoat-Chalumeau N; Crowther M; de Jesús G; Delluc A; Desai S; Sancho M; Devreese KM; Diz-Kucukkaya R; Duarte-García A; Frances C; et alii...

2023
ASL Città di Torino

Roccatello D; Careddu A; Ferro M; Naretto C; Quattrocchio G; Fenoglio R; Sciascia S;

Prevalence and clinical significance of ANCA positivity in lupus nephritis: a case series of 116 patients and literature review. in Journal of nephrology / J Nephrol. 2023 May;36(4):1059-1070. doi: 10.1007/s40620-023-01574-3. Epub 2023 Mar 20.
2023
ASL Città di Torino

Lacetera R; Calatroni M; Roggero L; Radice A; Pozzi MR; Reggiani F; Sciascia S; Trezzi B; Roccatello D; Minetti E; Moroni G; Sinico RA;

Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocol. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2023 Mar;41(3):597-604. doi: 10.55563/clinexprheumatol/qa2yb4. Epub 2022 Oct 28.
2023
ASL Città di Torino

Sciascia S; Radin M; Cecchi I; Barinotti A; Rubini E; Rossi D; Fenoglio R; Vaccarino A; Menegatti E; Roccatello D; Sciascia S; Radin M; Cecchi I; Barinotti A; Rubini E; Rossi D; Fenoglio R; Vaccarino A; Menegatti E; Roccatello D;

Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study. in RMD open / RMD Open. 2023 Jun;9(2):e002830. doi: 10.1136/rmdopen-2022-002830.
2023
ASL Città di Torino

Mekinian A; Biard L; Lorenzo D; Novikov PI; Salvarani C; Espitia O; Sciascia S; Michaud M; Lambert M; Hernández-Rodríguez J; Schleinitz N; Awisat A; Puechal X; Aouba A; Munoz Pons H; Smitienko I; Gaultier JB; Edwige LM; Benhamou Y; Perlat A; Jego P; Goulenok T; Sacre K; Lioger B; Hassold N; Broner J; Dufrost V; Sené T; Seguier J; et alii...

Health inequalities and social determinants of health: The role of syndemics in rheumatic diseases. in Autoimmunity reviews / Autoimmun Rev. 2023 Jul;22(7):103351. doi: 10.1016/j.autrev.2023.103351. Epub 2023 Apr 28.
2023
ASL Città di Torino

Gilcrease GW; Sciascia S; Padovan D; Sciullo A; Cioffi M; Ricceri F; Radin M; Schreiber K; Husum D; Roccatello D; Nikiphorou E;

Reply to comment on: Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2023 Jan;41(1):197. doi: 10.55563/clinexprheumatol/g1a1u3. Epub 2022 Oct 13.
2023
ASL Città di Torino

Radin M; Rubini E; Cecchi I; Foddai SG; Barinotti A; Rossi D; Sciascia S; Roccatello D; Radin M; Rubini E; Cecchi I; Foddai SG; Barinotti A; Rossi D; Sciascia S; Roccatello D;

The role of bacteria and viruses in Behçet syndrome: Should we move towards new paradigms? in Autoimmunity reviews / Autoimmun Rev. 2023 Feb;22(2):103237. doi: 10.1016/j.autrev.2022.103237. Epub 2022 Nov 19.
2023
ASL Città di Torino

Sciascia S; Arbrile M; Trunfio M; Calcagno A; Radin M; Roccatello D; Lembo D; Civra A;

Daratumumab monotherapy for refractory lupus nephritis. in Nature medicine / Nat Med. 2023 Aug;29(8):2041-2047. doi: 10.1038/s41591-023-02479-1. Epub 2023 Aug 10.
2023
ASL Città di Torino

Roccatello D; Fenoglio R; Caniggia I; Kamgaing J; Naretto C; Cecchi I; Rubini E; Rossi D; De Simone E; Del Vecchio G; Cozzi M; Sciascia S;

Antiphospholipid Syndrome and Kidney Involvement. in Kidney & blood pressure research / Kidney Blood Press Res. 2023;48(1):666-677. doi: 10.1159/000529229. Epub 2023 Sep 21.
2023
ASL Città di Torino
AOU Città della Salute di Torino

Barreca A; Roccatello D; Oddone V; Fenoglio R; Sciascia S; De Simone E;

Unmet needs in countries participating in the undiagnosed diseases network international: an international survey considering national health care and economic indicators. in Frontiers in public health / Front Public Health. 2023 Sep 26;11:1248260. doi: 10.3389/fpubh.2023.1248260. eCollection 2023.
2023
ASL Città di Torino

Sciascia S; Roccatello D; Salvatore M; Carta C; Cellai LL; Ferrari G; Lumaka A; Groft S; Alanay Y; Azam M; Baynam G; Cederroth H; Cutiongco-de la Paz EM; Dissanayake VHW; Giugliani R; Gonzaga-Jauregui C; Hettiarachchi D; Kvlividze O; Landoure G; Makay P; Melegh B; Ozbek U; Puri RD; Romero VI; Scaria V; Jamuar SS; Shotelersuk V; Gahl WA; Wiafe SA; et alii...

Chronic glucocorticoid maintenance treatment is associated with the risk of SARS-CoV-2 infection in patients with systemic lupus erythematosus who received vaccination. in Annals of the rheumatic diseases / Ann Rheum Dis. 2022 Sep 12;81(10):1476-1477. doi: 10.1136/ard-2022-222832.
2022
ASL Città di Torino

Ramirez GA; Argolini LM; Schioppo T; Sciascia S; Moroni L; Moroni G; Sinico RA; Bonelli G; Alberici F; Mescia F; Tamborini F; Miraglia P; Bellocchi C; Beretta L; Roccatello D; Bozzolo EP; Caporali R; Gerosa M; Dagna L;

Erratum: Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS). in Thrombosis and haemostasis / Thromb Haemost. 2022 Sep;122(9):e1. doi: 10.1055/s-0043-1769787. Epub 2023 May 24.
2022
ASL Città di Torino

Sciascia S; Foddai SG; Alessandri C; Alunno A; Andreoli L; Barinotti A; Calligaro A; Canti V; Carubbi F; Cecchi I; Chighizola CB; Conti F; Emmi G; Fioravanti A; Fischetti F; Franceschini F; Gerosa M; Hoxha A; Larosa M; Lazzaroni MG; Nalli C; Pazzola G; Radin M; Raffeiner B; Ramoni VL; Rubini E; Sebastiani GD; Truglia S; Urban ML; et alii...

2022
ASL Città di Torino

Sciascia S; Foddai SG; Alessandri C; Alunno A; Andreoli L; Barinotti A; Calligaro A; Canti V; Carubbi F; Cecchi I; Chighizola CB; Conti F; Emmi G; Fioravanti A; Fischetti F; Franceschini F; Gerosa M; Hoxha A; Larosa M; Lazzaroni MG; Nalli C; Pazzola G; Radin M; Raffeiner B; Ramoni VL; Rubini E; Sebastiani GD; Truglia S; Urban ML; et alii...

Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2022 Mar;40(3):575-580. doi: 10.55563/clinexprheumatol/7vp1bo. Epub 2021 Jun 26.
2022
ASL Città di Torino

Foddai SG; Cecchi I; Rubini E; Radin M; Barinotti A; Rossi D; Sciascia S; Roccatello D;

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. in Annals of the rheumatic diseases / Ann Rheum Dis. 2022 Jun;81(6):768-779. doi: 10.1136/annrheumdis-2021-221733. Epub 2022 Feb 2.
2022
ASL Città di Torino

Drosos GC; Vedder D; Houben E; Boekel L; Atzeni F; Badreh S; Boumpas DT; Brodin N; Bruce IN; González-Gay MÁ; Jacobsen S; Kerekes G; Marchiori F; Mukhtyar C; Ramos-Casals M; Sattar N; Schreiber K; Sciascia S; Svenungsson E; Szekanecz Z; Tausche AK; Tyndall A; van Halm V; Voskuyl A; Macfarlane GJ; Ward MM; Nurmohamed MT; Tektonidou MG;

Differentiating between UCTD and early-stage SLE: from definitions to clinical approach. in Nature reviews. Rheumatology / Nat Rev Rheumatol. 2022 Jan;18(1):9-21. doi: 10.1038/s41584-021-00710-2. Epub 2021 Nov 11.
2022
ASL Città di Torino

Mosca M; Pons-Estel G; Yazdany J; Parodis I; Radin M; Roccatello D; Sciascia S;

COVID-19 in Pregnant Women With Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance. in The Journal of rheumatology / J Rheumatol. 2022 Jan;49(1):110-114. doi: 10.3899/jrheum.210480. Epub 2021 Sep 1.
2022
ASL Città di Torino

Bermas BL; Gianfrancesco M; Tanner HL; Seet AM; Aguiar MC; Al Adhoubi NK; Al Emadi S; Cunha BM; Flood R; Kusevich DA; McCarthy EM; Patel NJ; Ruderman EM; Sattui SE; Sciascia S; Siddique F; Valenzuela-Almada MO; Wise LM; Worthing AB; Zell J; Bhana S; Costello W; Duarte-Garcia A; Grainger R; Gossec L; Hausmann JS; Hyrich K; Lawson-Tovey S; Liew JW; et alii...

Quality of life measures in Systemic Lupus Erythematosus: A systematic review. in Reumatismo / Reumatismo. 2022 Feb 7;73(4). doi: 10.4081/reumatismo.2021.1447.
2022
ASL Città di Torino

Radin M; El Hasbani G; Barinotti A; Roccatello D; Uthman I; Taher A; Sciascia S;

Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTOR App. in International journal of environmental research and public health / Int J Environ Res Public Health. 2022 Apr 28;19(9):5379. doi: 10.3390/ijerph19095379.
2022
ASL Città di Torino

Radin M; Arbrile M; Cecchi I; Di Nunzio P; Buccarano N; Di Gregorio F; Milone V; Osella S; Crosasso P; Favuzzi MD; Barinotti A; Baldovino S; Menegatti E; Rossi D; Sciascia S; Roccatello D;

Efficacy and safety of TNF-? antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patients. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2022 Apr 11;61(4):1376-1384. doi: 10.1093/rheumatology/keab635.
2022
ASL Città di Torino

Mekinian A; Biard L; Dagna L; Novikov P; Salvarani C; Espitia O; Sciascia S; Michaud M; Lambert M; Hernández-Rodríguez J; Schleinitz N; Awisat A; Puéchal X; Aouba A; Munoz Pons H; Smitienko I; Gaultier JB; Le Mouel E; Benhamou Y; Perlat A; Jego P; Goulenok T; Sacre K; Lioger B; Hassold N; Broner J; Dufrost V; Sene T; Seguier J; et alii...

Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome. in Frontiers in immunology / Front Immunol. 2022 Sep 12;13:957201. doi: 10.3389/fimmu.2022.957201. eCollection 2022.
2022
ASL Città di Torino

Naranjo L; Stojanovich L; Djokovic A; Andreoli L; Tincani A; Ma?li?ska M; Sciascia S; Infantino M; Garcinuño S; Kostyra-Grabczak K; Manfredi M; Regola F; Stanisavljevic N; Milanovic M; Saponjski J; Roccatello D; Cecchi I; Radin M; Benucci M; Pleguezuelo D; Serrano M; Shoenfeld Y; Serrano A;

Renal Involvement in Transthyretin Amyloidosis: The Double Presentation of Transthyretin Amyloidosis Deposition Disease. in Nephron / Nephron. 2022;146(5):481-488. doi: 10.1159/000522370. Epub 2022 Mar 18.
2022
ASL Città di Torino

Fenoglio R; Baldovino S; Barreca A; Bottasso E; Sciascia S; Sbaiz L; Papotti M; Roccatello D;

Psychosocial burden in young patients with primary anti-phospholipid syndrome: an Italian nationwide survey (The AQUEOUS study). in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2021 Sep-Oct;39(5):938-946. doi: 10.55563/clinexprheumatol/2b73dn. Epub 2020 Sep
2021
ASL Città di Torino

Chighizola CB; Crisafulli F; Hoxha A; Carubbi F; Bellan M; Monti S; Costa L; Baldi C; Radin M; Praino E; Coletto LA; Pregnolato F; Sciascia S; Sainaghi PP; Bellis E; Ramoni V; Quartuccio L; Alunno A; Gerosa M; Andreoli L;

The global antiphospholipid syndrome score in women with systemic lupus erythematosus and adverse pregnancy outcomes. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2021 Sep-Oct;39(5):1071-1076. doi: 10.55563/clinexprheumatol/c96ief. Epub 2020 N
2021
ASL Città di Torino

Schreiber K; Radin M; Cecchi I; Rubini E; Roccatello D; Jacobsen S; Cuadrado MJ; Sciascia S;

Quality of life in patients with antiphospholipid antibodies differs according to antiphospholipid syndrome damage index (DIAPS). in European journal of internal medicine / Eur J Intern Med. 2021 Oct;92:134-136. doi: 10.1016/j.ejim.2021.07.004. Epub 2021 Jul 28.
2021
ASL Città di Torino

Radin M; Foddai SG; Cecchi I; Roccatello D; Sciascia S;

Clinical exome sequencing is a powerful tool in the diagnostic flow of monogenic kidney diseases: an Italian experience. in Journal of nephrology / J Nephrol. 2021 Oct;34(5):1767-1781. doi: 10.1007/s40620-020-00898-8. Epub 2020 Nov 23.
2021
ASL Alessandria
ASL Cuneo 1
ASL Città di Torino
ASL Torino 3
ASL Torino 4
ASL VCO
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Deaglio S; Amoroso A; Roccatello D; Peruzzi L; Chiappero F; Savoldi S; Ungari S; Borzumati M; Cantaluppi V; Bussolino S; Biancone L; Calabrese G; Vitale C; Tamagnone M; Sciascia S; Fenoglio R; Rollino C; Baldovino S; Benvenuta C; Cocchi E; Pelle A; Giachino D; Togliatto G; Vanzino SB; Rendine S; Arruga F; Bracciamà V; Callegari M; Kalantari S; et alii...

Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). in The European respiratory journal / Eur Respir J. 2021 May 6;57(5):2004158. doi: 10.1183/13993003.04158-2020. Print 2021 May.
2021
ASL Città di Torino
AO Ordine Mauriziano
AOU Città della Salute di Torino

Prisco D; Vaglio A; Emmi G; Willeit P; Olivotto I; Kiechl S; Palmisano A; Dejaco C; Willeit J; Maritati F; Marvisi C; Pellecchio M; Tomietto P; Pazzola G; Tedesco M; Bond M; Priori R; Gabrielli A; Jeannin G; Padula A; Cauli A; Racanelli V; Berti A; Bortolotti R; Venerito V; Iannone F; Badiu I; Rolla G; Bortoluzzi A; et alii...

Clinical manifestations in patients with antiphospholipid antibodies: Beyond thrombosis and pregnancy loss. in Lupus / Lupus. 2021 May;30(6):884-892. doi: 10.1177/0961203321995248. Epub 2021 Feb 16.
2021
ASL Città di Torino

Cecchi I; Radin M; Rubini E; Foddai SG; Barinotti A; Roccatello D; Sciascia S;

Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2021 Mar 2;60(3):1106-1113. doi: 10.1093/rheumatology/kez596.
2021
ASL Città di Torino
AO Ordine Mauriziano
AOU Città della Salute di Torino

Rossi D; Mengozzi G; Roccatello D; Bazzan M; Giachino O; Baldovino S; Vaccarino A; Cecchi I; Bertolaccini ML; Bertero MT; Rubini E; Radin M; Sciascia S;

Reducing the diagnostic delay in Antiphospholipid Syndrome over time: a real world observation. in Orphanet journal of rare diseases / Orphanet J Rare Dis. 2021 Jun 16;16(1):280. doi: 10.1186/s13023-021-01906-1.
2021
ASL Città di Torino

Radin M; Foddai SG; Barinotti A; Cecchi I; Rubini E; Sciascia S; Roccatello D;

2021
ASL Città di Torino

Radin M; Foddai S; Cecchi I; Rubini E; Barinotti A; Mahler M; Seaman A; Ramirez C; Casas S; Roccatello D; Sciascia S;

The role of antirheumatics in patients with COVID-19. in The Lancet. Rheumatology / Lancet Rheumatol. 2021 Jun;3(6):e447-e459. doi: 10.1016/S2665-9913(21)00062-X. Epub 2021 Mar 30.
2021
ASL Città di Torino

Nissen CB; Sciascia S; de Andrade D; Atsumi T; Bruce IN; Cron RQ; Hendricks O; Roccatello D; Stach K; Trunfio M; Vinet É; Schreiber K;

16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome. in Lupus / Lupus. 2021 Jul;30(8):1314-1326. doi: 10.1177/09612033211020361. Epub 2021 May 27.
2021
ASL Città di Torino

Sciascia S; Radin M; Cecchi I; Levy RA; Erkan D;

Community Garden Initiatives Addressing Health and Well-Being Outcomes: A Systematic Review of Infodemiology Aspects, Outcomes, and Target Populations. in International journal of environmental research and public health / Int J Environ Res Public Health. 2021 Feb 17;18(4):1943. doi: 10.3390/ijerph18041943.
2021
ASL Città di Torino

Gregis A; Ghisalberti C; Sciascia S; Sottile F; Peano C;

Health Disparities in Rheumatic Diseases: Understanding Global Challenges in Africa, Europe, Latin America, and Asia and Proposing Strategies for Improvement. in Rheumatic diseases clinics of North America / Rheum Dis Clin North Am. 2021 Feb;47(1):119-132. doi: 10.1016/j.rdc.2020.09.009.
2021
ASL Città di Torino

Dey D; Sciascia S; Pons-Estel GJ; Ding H; Shen N;

Endothelial dysfunction and cardiovascular risk in lupus nephritis: New roles for old players? in European journal of clinical investigation / Eur J Clin Invest. 2021 Feb;51(2):e13441. doi: 10.1111/eci.13441. Epub 2020 Nov 15.
2021
ASL Città di Torino

Mancardi D; Arrigo E; Cozzi M; Cecchi I; Radin M; Fenoglio R; Roccatello D; Sciascia S;

2021
ASL Città di Torino

Radin M; Schreiber K; Cecchi I; Bortoluzzi A; Crisafulli F; de Freitas CM; Bacco B; Rubini E; Foddai SG; Padovan M; Gallo Cassarino S; Franceschini F; Andrade D; Benedetto C; Govoni M; Bertero T; Marozio L; Roccatello D; Andreoli L; Sciascia S;

Antiphospholipid antibodies and cerebrovascular thrombosis in the pediatric population: Few answers to many questions. in Lupus / Lupus. 2021 Aug;30(9):1365-1377. doi: 10.1177/09612033211021488. Epub 2021 Jun 4.
2021
ASL Città di Torino

Hasbani GE; Taher AT; Sunji N; Sciascia S; Uthman I;

Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies. in Immunologic research / Immunol Res. 2021 Aug;69(4):372-377. doi: 10.1007/s12026-021-09208-1. Epub 2021 Jul 10.
2021
ASL Città di Torino

Radin M; Barinotti A; Foddai SG; Cecchi I; Rubini E; Roccatello D; Menegatti E; Sciascia S;

The effect of hydroxychloroquine on platelet activation in model experiments. in Journal of thrombosis and thrombolysis / J Thromb Thrombolysis. 2021 Aug;52(2):674-679. doi: 10.1007/s11239-020-02325-y. Epub 2021 Jan 2.
2021
ASL Città di Torino

Schreiber K; Sciascia S; Wehrmann F; Weiß C; Leipe J; Krämer BK; Stach K;

Utilizing type I interferon expression in the identification of antiphospholipid syndrome subsets. in Expert review of clinical immunology / Expert Rev Clin Immunol. 2021 Apr;17(4):395-406. doi: 10.1080/1744666X.2021.1901581. Epub 2021 Mar 3
2021
ASL Città di Torino

Cecchi I; Radin M; Rodríguez-Carrio J; Tambralli A; Knight JS; Sciascia S;

Efficacy of low or standard rituximab-based protocols and comparison to Ponticelli's regimen in membranous nephropathy. in Journal of nephrology / J Nephrol. 2021 Apr;34(2):565-571. doi: 10.1007/s40620-020-00781-6. Epub 2020 Jun 27.
2021
ASL Città di Torino

Fenoglio R; Baldovino S; Sciascia S; De Simone E; Del Vecchio G; Ferro M; Quattrocchio G; Naretto C; Roccatello D;

2021
ASL Città di Torino
AOU Città della Salute di Torino

Barreca A; Solfietti L; Kalikatzaros I; Viziello L; Ventrella F; Kamgaing J; Baldovino S; Ferro M; Fenoglio R; Sciascia S; Rossi D; Roccatello D;

Antiphospholipid Antibodies and Infection: Non Nova Sed Nove. in Frontiers in immunology / Front Immunol. 2021 Jun 16;12:687534. doi: 10.3389/fimmu.2021.687534. eCollection 2021.
2021
ASL Città di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Bacco B; Gallo Cassarino S; Roccatello D; Carignola R; Cosseddu D; Norbiato C; Bertero MT; Montaruli B; Bazzan M; Radin M; Sciascia S;

Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study. in Frontiers in medicine / Front Med (Lausanne). 2021 Feb 1;8:621590. doi: 10.3389/fmed.2021.621590. eCollection 2021.
2021
ASL Città di Torino

Sciascia S; Radin M; Cecchi I; Rubini E; Foddai SG; Barinotti A; Vaccarino A; Rossi D; Roccatello D;

Prognostic and Diagnostic Values of Novel Serum and Urine Biomarkers in Lupus Nephritis: A Systematic Review. in American journal of nephrology / Am J Nephrol. 2021;52(7):559-571. doi: 10.1159/000517852. Epub 2021 Aug 13.
2021
ASL Città di Torino

Radin M; Miraglia P; Barinotti A; Fenoglio R; Roccatello D; Sciascia S;

Vedolizumab for the Management of Refractory Behçet's Disease: From a Case Report to New Pieces of Mosaic in a Complex Disease. in Frontiers in immunology / Front Immunol. 2021 Oct 25;12:769785. doi: 10.3389/fimmu.2021.769785. eCollection 2021.
2021
ASL Città di Torino

Arbrile M; Radin M; Rossi D; Menegatti E; Baldovino S; Sciascia S; Roccatello D;

Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2020 May-Jun;38(3):529-532. Epub 2020 May 1.
2020
ASL Città di Torino

Sciascia S; Aprà F; Baffa A; Baldovino S; Boaro D; Boero R; Bonora S; Calcagno A; Cecchi I; Cinnirella G; Converso M; Cozzi M; Crosasso P; De Iaco F; Di Perri G; Eandi M; Fenoglio R; Giusti M; Imperiale D; Imperiale G; Livigni S; Manno E; Massara C; Milone V; Natale G; Navarra M; Oddone V; Osella S; Piccioni P; et alii...

Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection. in Thrombosis research / Thromb Res. 2020 Dec;196:432-434. doi: 10.1016/j.thromres.2020.09.039. Epub 2020 Oct 8.
2020
ASL Città di Torino

Bonora S; Roccatello D; Sciascia S; Lipani F; Gaviraghi A; Trentalange A; Marinaro L; Alcantarini C; Cabodi D; Salvador E; Trunfio M; Di Perri G; Calcagno A;

Patients with antiphosholipid syndrome and thrombotic recurrences: A real world observation (the Piedmont cohort study). in Lupus / Lupus. 2016 Apr;25(5):479-85. doi: 10.1177/0961203315617538. Epub 2015 Dec 8.
2016
ASL Città di Torino

Bazzan M; Vaccarino A; Stella S; Sciascia S; Montaruli B; Bertero MT; Carignola R; Roccatello D;

Antiphospholipid Syndrome and the Kidney. in Seminars in nephrology / Semin Nephrol. 2015 Sep;35(5):478-86. doi: 10.1016/j.semnephrol.2015.08.009.
2015
ASL Città di Torino

Sciascia S; Baldovino S; Schreiber K; Solfietti L; Roccatello D;

2015
ASL Città di Torino

Roccatello D; Sciascia S; Baldovino S; Rossi D; Alpa M; Naretto C; Di Simone D; Simoncini M; Menegatti E;

Rheumatoid arthritis: Biological therapy other than anti-TNF. in International immunopharmacology / Int Immunopharmacol. 2015 Aug;27(2):185-8. doi: 10.1016/j.intimp.2015.03.019. Epub 2015 Mar 31.
2015
ASL Città di Torino

Rossi D; Modena V; Sciascia S; Roccatello D;

The role of nail-videocapillaroscopy in early diagnosis of scleroderma. in Autoimmunity reviews / Autoimmun Rev. 2013 Jun;12(8):821-5. doi: 10.1016/j.autrev.2012.11.006. Epub 2012 Dec 4.
2013
ASL Città di Torino

Rossi D; Russo A; Manna E; Binello G; Baldovino S; Sciascia S; Roccatello D;